Cancer clinical trials in the region Auvergne-Rhône-Alpes
360 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
EGFR
None
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
2
3 or more
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
1
Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
1
Systemic Treatment-Naive
Hoffmann-La Roche
Phase 3
Endometrial cancer
#NCT06952504
#2024-519331-42-00
Endometrioid adenocarcinoma
Serous adenocarcinoma
Clear cell carcinoma
Dedifferentiated and undifferentiated endometrial ...
Locally Advanced
Metastatic
MSS/pMMR
Unknown
None
Systemic Treatment-Naive
MSI/dMMR
Immunotherapy
Antibody Drug Conjugates (ADC)
Immunotherapy
Antibody Drug Conjugates (ADC)
Centre Léon Bérard (Lyon)
Merck Sharp & Dohme LLC
Phase 3
Lung cancer
#NCT06890598
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
KRAS G12C
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
None
Chemotherapy
Radiotherapy
ALK
EGFR
Centre Léon Bérard (Lyon), Hôpital Louis Pradel (Bron ), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Eli Lilly et compagnie
Phase 3
Lung cancer
#NCT06890598
NSCLC (Non-Small Cell Lung Cancer)
Localized
Locally Advanced
KRAS G12C
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
None
Surgery
Immunotherapy
Chemotherapy
ALK
EGFR
Centre Léon Bérard (Lyon), Hôpital Louis Pradel (Bron ), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Eli Lilly et compagnie
Phase 3
Colon cancer
Rectal cancer
Pancreas cancer
Stomach and esophageal cancer
#NCT06937905
Neuroendocrine tumor
Locally Advanced
Metastatic
1
Chemotherapy
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), Centre Léon Bérard (Lyon), Hôpital Edouard Herriot - Hospices Civils de Lyon (Lyon), Hôpitaux Nord-Ouest - Villefranche-sur-Saône (Gleizé) (and 1 more...)
Intergroupe Francophone de Cancérologie Thoracique